Orchid Pharma Complete Financial Statements
ORCHPHARMA • Review detailed financials to uncover trends, confirm thesis & journal trades
11 Years of Data
2025 - 2015
Complete Financial Data Export
Export complete financial statements for Orchid Pharma (ORCHPHARMA).
Downloads include all available records across all periods.
For market performance, see the
ORCHPHARMA stock price today
.
Profitability Ratios
Net Profit Margin
-2.94%
2025 data
EBITDA Margin
4.41%
2025 data
Operating Margin
-1.00%
2025 data
Return on Assets
-0.36%
2025 data
Return on Equity
-0.47%
2025 data
Balance Sheet Ratios
Current Ratio
5.98
2025 data
Debt to Equity
1.33
2025 data
Equity Ratio
75.06%
2025 data
Asset Turnover
0.12
2025 data
Year-over-Year Growth Analysis
Comparing Sept 2024 vs Sept 2025
Revenue Growth
-11.3%
Year-over-Year
Net Profit Growth
-122.2%
Year-over-Year
EBITDA Growth
-76.3%
Year-over-Year
Expense Growth
+1.6%
Year-over-Year
Assets Growth
+8.6%
Year-over-Year
Equity Growth
+8.3%
Year-over-Year
Liabilities Growth
+8.6%
Year-over-Year
Operating Cash Flow Growth
-84.9%
Year-over-Year
Investing Cash Flow Growth
+91.3%
Year-over-Year
Financing Cash Flow Growth
-85.0%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 | Sept 2022 | Mar 2022 | Jun 2022 | Dec 2022 | Sept 2021 | Mar 2021 | Jun 2021 | Dec 2021 | Sept 2020 | Mar 2020 | Jun 2020 | Dec 2020 | Sept 2019 | Jun 2019 | Dec 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 204 | 241 | 184 | 230 | 231 | 252 | 226 | 207 | 251 | 185 | 228 | 171 | 180 | 134 | 169 | 196 | 131 | 95 | 164 | 110 | 93 | 120 | 105 | 138 | 141 | 137 |
| Expenses | 195 | 210 | 159 | 192 | 188 | 212 | 191 | 175 | 177 | 161 | 185 | 147 | 154 | 119 | 146 | 116 | 123 | 95 | 151 | 91 | 108 | 100 | 108 | 133 | 148 | 129 |
| EBITDA | 9 | 32 | 26 | 38 | 42 | 40 | 35 | 32 | 74 | 24 | 43 | 24 | 26 | 15 | 23 | 79 | 8 | 0 | 13 | 19 | -15 | 21 | -3 | 6 | -7 | 7 |
| Operating Profit Margin % | -1.00% | 12.00% | 8.00% | 14.00% | 13.00% | 13.00% | 12.00% | 12.00% | 16.00% | 12.00% | 16.00% | 11.00% | 13.00% | 10.00% | 9.00% | 9.00% | -3.00% | -3.00% | 7.00% | 17.00% | -23.00% | 16.00% | -5.00% | -1.00% | -9.00% | 0.00% |
| Depreciation | 9 | 9 | 9 | 9 | 8 | 8 | 9 | 8 | 7 | 8 | 9 | 18 | 27 | 22 | 8 | 20 | 20 | 20 | 20 | 30 | 23 | 30 | 29 | 32 | 31 | 32 |
| Interest | 4 | 4 | 3 | 3 | 4 | 4 | 4 | 4 | 8 | 6 | 4 | 9 | 5 | 8 | 8 | 10 | 12 | 11 | 7 | 13 | 1 | 14 | 13 | 0 | 0 | 3 |
| Profit Before Tax | -3 | 19 | 14 | 26 | 30 | 28 | 23 | 20 | 59 | 11 | 30 | -3 | -6 | -14 | 7 | 49 | -25 | -31 | -14 | -24 | -39 | -23 | -45 | -26 | -39 | -28 |
| Tax | 2 | -3 | -1 | -1 | -3 | -1 | 2 | 0 | 0 | 1 | 1 | 2 | 1 | 1 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -6 | 22 | 15 | 27 | 33 | 29 | 21 | 20 | 59 | 9 | 29 | -5 | -7 | -15 | 8 | 49 | -25 | -31 | -14 | -24 | -39 | -23 | -45 | -26 | -39 | -28 |
| Earnings Per Share (₹) | -1.13 | 4.40 | 2.94 | 5.37 | 6.81 | 5.79 | 4.10 | 4.30 | 14.49 | 1.85 | 6.18 | -1.32 | -1.61 | -3.68 | 1.86 | 12.10 | -6.06 | -7.57 | -3.40 | -5.98 | -9.52 | -5.55 | -10.96 | -2.93 | -4.32 | -3.11 |
Related Pages for Orchid Pharma
Additional stock information and data for ORCHPHARMA
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 1,688 | 1,554 | 1,225 | 1,111 | 1,237 | 1,460 | 3,077 | 3,125 | 3,256 | 3,862 | 4,061 |
| Current Assets | 807 | 791 | 501 | 398 | 550 | 569 | 768 | 679 | 675 | 1,251 | 1,278 |
| Fixed Assets | 633 | 620 | 573 | 584 | 670 | 858 | 1,256 | 1,386 | 1,497 | 1,637 | 1,795 |
| Capital Work in Progress | 81 | 31 | 47 | 10 | 7 | 26 | 278 | 272 | 288 | 280 | 282 |
| Investments | 50 | 46 | 44 | 46 | 15 | 0 | 1 | 1 | 1 | 0 | 0 |
| Other Assets | 925 | 857 | 561 | 472 | 544 | 576 | 1,542 | 1,467 | 1,470 | 1,945 | 1,985 |
| LIABILITIES | |||||||||||
| Total Liabilities | 1,688 | 1,554 | 1,225 | 1,111 | 1,237 | 1,460 | 3,077 | 3,125 | 3,256 | 3,862 | 4,061 |
| Current Liabilities | 135 | 124 | 165 | 222 | 442 | 519 | 1,436 | 1,905 | 2,212 | 2,475 | 2,609 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | 1,267 | 1,170 | 689 | 647 | 653 | 766 | -704 | -792 | -467 | 49 | 329 |
| Share Capital | 51 | 51 | 41 | 41 | 41 | 41 | 89 | 89 | 89 | 89 | 85 |
| Reserves & Surplus | 1,148 | 1,050 | 579 | 538 | 544 | 725 | -793 | -881 | -556 | -40 | 244 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 19 | 126 | 18 | 93 | 24 | 81 | 12 | 9 | 401 | 212 | -369 |
| Investing Activities | -27 | -312 | -31 | 113 | 67 | 167 | 46 | -28 | -176 | -2 | 1,334 |
| Financing Activities | 25 | 167 | 31 | -217 | -165 | -250 | 0 | 33 | -465 | -286 | -597 |
| Net Cash Flow | 18 | -19 | 18 | -11 | -74 | -2 | 57 | 15 | -240 | -76 | 367 |